Try it
General Medicine · Haematology and oncology: anticoagulation in cancer-associated thrombosis
Sample itemA 60-year-old woman with metastatic pancreatic cancer develops a proximal deep vein thrombosis. Which anticoagulant approach is preferred for long-term treatment?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Low-molecular-weight heparin or a DOAC
In cancer-associated venous thromboembolism, LMWH or a DOAC is preferred over vitamin K antagonists, which have more recurrence and unstable INR control from poor intake and chemotherapy interactions. A filter is reserved for those who cannot be anticoagulated.
Option by option
A. Warfarin alone without heparin overlap
Warfarin without overlap is unsafe initially and less effective in cancer.
B. Inferior vena cava filter placement alone
A filter alone does not treat the clot and is used when anticoagulation is contraindicated.
C. Low-molecular-weight heparin or a DOAC (correct)
Correct. LMWH or a DOAC gives lower recurrence than warfarin in malignancy.
D. Aspirin alone for a period of six months
Aspirin is not adequate treatment for a proximal DVT.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…
- NeurologyA chronic alcohol user is brought in confused, with nystagmus and an unsteady gait. What…